drugset / Trial / NCT01581320
Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A multicenter, randomized, double-blind, active-controlled, phase III clinical trial to evaluate the efficacy and safety of Dp-R206 and Bonviva for 16 weeks once a month on the improvement of vitamin D in postmenopausal women with osteoporosis.
Timeline
- Start
- 2011-12
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 24000 iu | — |
| Subject | Ibandronate | Other / unclassified | 150 mg | — |